Repair, as opposed to regeneration, requires "patching" rather than "restoring" tissue components. The quantity of regeneration vs. repair that happens is determined by the cells' proliferative capacity, the stromal framework's integrity, and the duration of the damage and inflammatory response. Tissue repair (TR) is the process of a tissue's compensatory regeneration after a surgical, mechanical, or chemical insult, resulting in the tissue's structure and function being restored. The implementation of treatment models that have become an established part of everyday practice is enabled by current understanding of certain of the tissue repair mechanisms. Management of the inflammatory process, cell proliferation (excessive or defective), and extracellular matrix (ECM) remodelling are all part of the healing process. Repair, as opposed to regeneration, requires "patching" rather than "restoring" tissue components. The quantity of regeneration vs. repair that happens is determined by the cells' proliferative capacity, the stromal framework's integrity, and the duration of the damage and inflammatory response. Tissue repair is a dynamic process that prevents injury from progressing to organ failure and death. It is influenced by species, strain, age, and other individual features. Tissue repair has been shown to increase in a dose-dependent way until a dosage threshold is reached. Low to moderate doses accelerate tissue healing, but as the dose increases, the onset becomes more delayed. As a result, at doses above a specific threshold, the tissue healing response is both too small and too late to stop the injury from progressing.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States